GFP
UTHR icon

Gryphon Financial Partners’s United Therapeutics UTHR Stock Holding History

Gryphon Financial Partners’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$862K Buy
1,591
+280
+21% +$158K 0.08% 168
2026
Q1 		$777K Buy
1,311
+132
+11% +$65.7K 0.08% 165
2025
Q4 		$574K Buy
1,179
+206
+21% +$95.9K 0.06% 195
2025
Q3 		$408K Sell
973
-19
-2% -$6.39K 0.05% 220
2025
Q2 		$285K Buy
992
+249
+34% +$74.4K 0.04% 256
2025
Q1 		$229K Buy
+743
New +$255K 0.03% 263
2024
Q4 		– Sell
-586
Closed -$210K – 288
2024
Q3 		$210K Buy
+586
New +$198K 0.03% 275
2019
Q3 		– Sell
-32
Closed -$2K – 171
2019
Q2 		$2K Buy
+32
New +$2.99K ﹤0.01% 151

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Gryphon Financial Partners's UTHR Position: Q2 2026 in Review

Gryphon Financial Partners increased its United Therapeutics (UTHR) stake by 21% in Q2 2026, buying an estimated $158K and bringing the position to 1,591 shares worth $862K. The position accounts for 0.08% of the portfolio, ranked #168.

Gryphon Financial Partners first reported a position in UTHR in Q2 2019 and has held it in 8 quarters since. 884 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

  • Gryphon Financial Partners held 1,591 shares of United Therapeutics worth $862K as of Q2 2026.
  • Gryphon Financial Partners bought 280 United Therapeutics shares in Q2 2026, an estimated $158K.
  • United Therapeutics made up 0.08% of Gryphon Financial Partners's portfolio in Q2 2026, its #168 holding.
  • Gryphon Financial Partners first reported a position in United Therapeutics in Q2 2019 and has held it in 8 quarters since.
  • 884 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on Gryphon Financial Partners's 13F filing for Q2 2026, filed 5 Aug 2026.